Analystreport

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com